Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 11:58 PM UTC
| NCT Number | NCT05123482 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | PHASE1 |
| Target Enrollment | 460 participants |
| Active Locations | 14 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 13, 2026 (5 days ago) |
As of October 18, 2026: Clinical trial NCT05123482 is currently recruiting participants. This phase1 study for advanced cancer is actively seeking new participants at 14 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05123482 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05123482 was last updated 5 days ago (October 13, 2026). HelloStudys verifies this status automatically.